Holen Sie sich die Stockscreener-App
2.39
0.42%
-0.010
Handel nachbörslich:
2.39
Schlusskurs vom Vortag:
$2.40
Offen:
$2.41
24-Stunden-Volumen:
113.42K
Relative Volume:
1.10
Marktkapitalisierung:
$98.00M
Einnahmen:
$2.70M
Nettoeinkommen (Verlust:
$5.53M
KGV:
21.73
EPS:
0.11
Netto-Cashflow:
$-10.55M
1W Leistung:
+0.00%
1M Leistung:
-9.47%
6M Leistung:
+3.02%
1J Leistung:
+0.42%
1-Tages-Spanne:
$2.32
$2.41
1-Wochen-Bereich:
$2.30
$2.43
52-Wochen-Spanne:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Firmenname
Oramed Pharmaceuticals Inc
Sektor
Branche
Telefon
646-844-1164
Adresse
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Vergleichen Sie ORMP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.39 | 98.41M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-12 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-02-09 | Eingeleitet | National Securities | Buy |
| 2020-12-03 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-03-11 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-12-11 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Bestätigt | FBR Capital | Outperform |
| 2015-12-01 | Bestätigt | H.C. Wainwright | Buy |
| 2015-11-19 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-13 | Fortgesetzt | MLV & Co | Buy |
| 2014-01-30 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Eingeleitet | MLV & Co | Buy |
| 2013-12-03 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Oramed Pharmaceuticals Inc Aktie (ORMP) Neueste Nachrichten
Why Oramed Pharmaceuticals Inc. (OJU1) stock fits value portfolios2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Why Oramed Pharmaceuticals Inc. stock is a must watch in 20252025 Valuation Update & Community Supported Trade Ideas - newser.com
Is Oramed Pharmaceuticals Inc a good long term investmentMoving Average Strategies & Superior Growth Investment - earlytimes.in
Is Oramed Pharmaceuticals Inc. stock a defensive play in 20252025 Geopolitical Influence & Community Consensus Trade Signals - newser.com
Ranking Oramed Pharmaceuticals Inc. among high performing stocks via toolsPortfolio Return Report & Weekly Market Pulse Updates - newser.com
Pattern recognition hints at Oramed Pharmaceuticals Inc. upsideQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
What does recent volatility data suggest for Oramed Pharmaceuticals Inc.July 2025 Closing Moves & Free High Return Stock Watch Alerts - newser.com
Using Ichimoku Cloud for Oramed Pharmaceuticals Inc. technicalsWeekly Profit Report & Verified Stock Trade Ideas - newser.com
Will Oramed Pharmaceuticals Inc. benefit from macro trends2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
How Oramed Pharmaceuticals Inc. stock reacts to global recession fearsMarket Activity Report & Weekly Chart Analysis and Guides - newser.com
Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthEarnings Miss & Real-Time Volume Trigger Notifications - newser.com
Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Increased to Hold at Wall Street Zen - MarketBeat
Applying sector rotation models to Oramed Pharmaceuticals Inc.July 2025 Review & Weekly High Potential Alerts - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock resilient in recession scenariosWeekly Volume Report & Growth Focused Investment Plans - newser.com
Custom watchlist performance reports with Oramed Pharmaceuticals Inc.Weekly Volume Report & Real-Time Volume Trigger Notifications - newser.com
Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversal2025 Price Action Summary & AI Driven Price Forecasts - newser.com
What recovery options are there for Oramed Pharmaceuticals Inc.July 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
Will Oramed Pharmaceuticals Inc. stock continue upward momentumEarnings Miss & Real-Time Sentiment Analysis - newser.com
Will breakout in Oramed Pharmaceuticals Inc. lead to full recoveryJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Tools to assess Oramed Pharmaceuticals Inc.’s risk profileJuly 2025 Technicals & High Conviction Buy Zone Alerts - newser.com
Oramed Pharm Repurchases Shares, Ends Joint Venture - MSN
Why Oramed Pharmaceuticals Inc. stock remains undervaluedPortfolio Risk Summary & Growth Focused Stock Reports - newser.com
Oramed Pharmaceuticals (ORMP) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):